Stocktoria
ALNYLAM PHARMACEUTICALS, INC. ALNY
ALNYLAM PHARMACEUTICALS, INC. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 9,547,663 | $2.3B | 7.09% |
| DODGE & COX | 1,955,393 | $588.6M | 1.45% |
| TWO SIGMA INVESTMENTS, LP | 1,875,937 | $564.7M | 1.39% |
| D. E. Shaw & Co., Inc. | 1,534,409 | $461.9M | 1.14% |
| AQR CAPITAL MANAGEMENT LLC | 728,039 | $219.0M | 0.54% |
| MILLENNIUM MANAGEMENT LLC | 379,201 | $114.2M | 0.28% |
| CITADEL ADVISORS LLC | 315,129 | $94.9M | 0.23% |
| Bridgewater Associates, LP | 99,584 | $30.0M | 0.07% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.